Identification and Characterization of Antigenically Advanced Variants to Accelerate and Improve Influenza Vaccine Development

Past New Requirement Updated

Agency
Solicitation expected
Not on record
Estimated value
$3,000,000 to $7,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
Not on record
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Department of Health and Human Services Centers for Disease Control and Prevention is seeking to procure research services focused on the identification and characterization of antigenically advanced influenza virus variants to enhance vaccine development processes. The primary objective appears to be supporting advanced immunological research that can accelerate and improve influenza vaccine design through comprehensive genetic and antigenic analysis. The estimated contract award date is February 1, 2025, with the opportunity originally posted on December 10, 2025, through the University of Wisconsin under procurement code 000HCJCB-2024-82234.

The point of contact for this forecasted opportunity is Charmaine McKenzie from the National Center for Immunization and Respiratory Diseases (NCIRD), who can be reached at buo4@cdc.gov. While specific award values and budget ranges are not provided in the current forecast, the contract appears to be unrestricted (no set-aside designation), suggesting potential accessibility for a broad range of research institutions and contractors. The research is likely to be conducted at the University of Wisconsin or in collaboration with CDC research facilities, with a focus on advancing influenza vaccine development through detailed scientific investigation.

Forecast text

University of Wisconsin - CVV activity; 000HCJCB-2024-82234

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast